Ke Bian

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2025
Sensitization of cancer cells to DNA-damaging agents by expression of the REV1 C-terminal domain: Implications for chemotherapy.

Ke Bian, Charley C Gruber, Emine Byers

|Apr 04, 2024
Stable Interstrand Cross-Links Generated from the Repair of 1,N6-Ethenoadenine in DNA by α-Ketoglutarate/Fe(II)-Dependent Dioxygenase ALKBH2.

Jie Wang, Nathania A Takyi, Yun-Chung Hsiao

|Nov 04, 2020
Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.

Faye-Marie Vassel, Ke Bian, Graham C Walker

|May 16, 2019
Hydrolyzable Tannins Are Iron Chelators That Inhibit DNA Repair Enzyme ALKBH2.

Fangyi Chen, Qi Tang, Hang Ma

Pageof 1